Last reviewed · How we verify
Latanoprost, 24-hour intraocular pressure monitoring
Latanoprost, 24-hour intraocular pressure monitoring is a Small molecule drug developed by Aristotle University Of Thessaloniki. It is currently FDA-approved. Also known as: Ganfort, Xalatan.
At a glance
| Generic name | Latanoprost, 24-hour intraocular pressure monitoring |
|---|---|
| Also known as | Ganfort, Xalatan |
| Sponsor | Aristotle University Of Thessaloniki |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- 24-Hour Intraocular Pressure Control With Bimatoprost/Timolol Versus Latanoprost as First Choice (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Latanoprost, 24-hour intraocular pressure monitoring CI brief — competitive landscape report
- Latanoprost, 24-hour intraocular pressure monitoring updates RSS · CI watch RSS
- Aristotle University Of Thessaloniki portfolio CI
Frequently asked questions about Latanoprost, 24-hour intraocular pressure monitoring
What is Latanoprost, 24-hour intraocular pressure monitoring?
Latanoprost, 24-hour intraocular pressure monitoring is a Small molecule drug developed by Aristotle University Of Thessaloniki.
Who makes Latanoprost, 24-hour intraocular pressure monitoring?
Latanoprost, 24-hour intraocular pressure monitoring is developed and marketed by Aristotle University Of Thessaloniki (see full Aristotle University Of Thessaloniki pipeline at /company/aristotle-university-of-thessaloniki).
Is Latanoprost, 24-hour intraocular pressure monitoring also known as anything else?
Latanoprost, 24-hour intraocular pressure monitoring is also known as Ganfort, Xalatan.
What development phase is Latanoprost, 24-hour intraocular pressure monitoring in?
Latanoprost, 24-hour intraocular pressure monitoring is FDA-approved (marketed).
Related
- Manufacturer: Aristotle University Of Thessaloniki — full pipeline
- Also known as: Ganfort, Xalatan
- Compare: Latanoprost, 24-hour intraocular pressure monitoring vs similar drugs
- Pricing: Latanoprost, 24-hour intraocular pressure monitoring cost, discount & access